Aristotle shareholder plans short-form merger for remaining shares

By Lisa Kerner

Charlotte, N.C., Aug. 25 - Aristotle Corp.'s majority stockholder, Geneve Corp., wants to acquire the balance of the company's shares of common stock and series I preferred stock that it does not already own via a short-term merger, according to a form 8-K filed with the Securities and Exchange Commission.

Each share of common stock would be converted into the right to receive $5.50 in cash, while each outstanding series I preferred would be converted into the right to receive $7.00 in cash, a schedule 13D/A filing said.

Geneve owns 90.6% of Aristotle's outstanding voting stock.

The short-form merger does not require any action by Aristotle's board of directors or its shareholders to become effective.

Aristotle, based in Stamford, Conn., manufactures and distributes educational, health, medical technology and agricultural products worldwide.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.